Reciprocal branding.

The practice of highly marketing clinical trials as a way to bolster both clientele (i.e., money) and study enrollment (i.e., reputation) is also bolstering false hope--by intention. Read this scathing editorial with care because your cancer center may be called out by name. | London, JAMA Oncol 2018